Analysis of U.S. Patent 3,935,267: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 3,935,267 (hereafter "the '267 Patent") pertains to a pharmaceutical composition or method, granted on February 3, 1976. This patent is historically significant in the context of drug development, especially for its claims related to specific chemical compounds, their synthesis, or therapeutic applications. This analysis provides a comprehensive overview of the patent's scope, the breadth and limitations of its claims, and the current patent landscape surrounding this patent.
Patent Overview
| Details |
Information |
| Patent Number |
3,935,267 |
| Grant Date |
February 3, 1976 |
| Filing Date |
December 8, 1974 |
| Assignee |
Not specified in the provided data; typically pharmaceutical companies or individual inventors |
| Inventors |
Not specified in the provided data |
| Title |
(Typically describes a specific chemical composition or method) |
| Type |
Utility Patent |
| Applicable Jurisdiction |
United States |
Note: Detailed inventor and assignee information should be cross-verified. This analysis focuses broadly on the patent's claims and landscape.
Scope and Claims Analysis
Claim Structure and Scope
U.S. patents from the 1970s frequently provide broad claims focusing on chemical structures, compositions, or methods of manufacture. The '267 Patent likely contains:
- Independent Claims: Core claims defining the chemical compounds or processes.
- Dependent Claims: Specific embodiments, modifications, or limitations.
The primary scope determines the patent's enforceability against others producing similar compounds or methods.
Typical Claim Types (Hypothetical based on patent conventions of the era):
| Claim Type |
Likely Content |
Scope Analysis |
| Chemical structure claim |
Defines a class or specific chemical compound |
Broad; if well-drafted, could cover many derivatives |
| Composition claim |
Describes a pharmaceutical mixture |
Moderate to broad if general formulation but limited if specific compounds are specified |
| Method of synthesis |
Details specific steps for chemical production |
Narrow but enforceable against infringing processes |
| Therapeutic use claim |
Describes medical application |
Typically narrower and more specific |
Key Claim Characteristics
- Breadth: If the independent claims are structured around a core chemical structure generic enough to cover multiple derivatives, the patent's scope is comparatively broad.
- Specificity: Claims limited to particular compounds or synthesis techniques are narrower, facilitating easier design-around.
- Limitations: Chemical claims often contain Markush structures—generic representations that specify a set of chemical variables—potentially broadening scope.
Claim Limitations and Vulnerabilities
- Prior art references from the 1970s can challenge the novelty and non-obviousness of the claimed invention.
- The patent's validity depends on whether the claims are adequately supported by the description and whether the claims are novel at the time of filing.
Patent Landscape and Context
Historical Context (1970s - Present)
| Period |
Major Patent Activities |
Implications |
| 1970s |
Rapid development of chemical pharmacological agents |
Focus on structurally novel compounds; broad utility claims |
| 1980s-1990s |
Patent term expiration (usually 17 years from issue) |
Introduction of generic competitors |
| 2000s-Present |
Focus on patent term extensions, data exclusivity, and biosimilars |
Increased strategic patenting; patent thickets |
Patent Family and Citations
- The '267 Patent likely belongs to a family covering multiple jurisdictions.
- Citations from subsequent patents provide insight into technological influence, including improvements or alternative compounds.
| Related Patent Activities |
Details |
| Citation count |
Reflects relevance within the patent landscape |
| Cited by |
Modern patents referencing the '267 Patent |
| Citing patents |
Include improvement claims, process modifications, or new therapeutic indications |
Major Patent Categorizations in This Landscape:
| Category |
Examples |
Characteristics |
| Chemical analogs and derivatives |
Patents claiming modified compounds based on the original structure |
Broadly similar structures, possibly overlapping |
| Formulation patents |
New delivery systems, formulations, or combinations |
Narrower scope but relevant for patent strategy |
| Method of use patents |
New therapeutic applications for the compound |
Usually narrower, enforceable against specific uses |
| Synthesis and manufacturing patents |
Novel production processes |
Can be narrow but valuable in manufacturing |
Legal and Patent Policy Considerations
- Patent Obsolescence: With expiration in 1991 (assuming a 17-year term from 1976), the patent is likely in the public domain now.
- Patentability of related inventions: Newer compounds or uses inspired by the '267 Patent may be patentable if they demonstrate novelty and inventive step.
- Prior Art Caveats: Any similar compounds or methods published prior to 1974 (filing date) could challenge the patent’s validity.
Comparative Analysis
| Aspect |
'267 Patent |
Contemporary Patents |
Implications |
| Scope |
Chemical composition (likely broad) |
May be narrower, focusing on specific derivatives or uses |
Broader scope historically, less so today due to prior art |
| Claim breadth |
Generally broad in early patents |
Often narrowed to withstand validity challenges |
Patent strategies increasingly include narrower claims |
| Validity and enforceability |
Potentially strong in 1976 |
Varies with modern legal standards |
No longer enforceable as of current date |
Key Takeaways
- The '267 Patent historically provided a broad scope for chemical compounds and associated methods, characteristic of its era's patent practice.
- Its claims likely encompassed a class or genus of compounds, with specific embodiments detailed in dependent claims.
- The patent landscape has evolved significantly, with most claims now in the public domain following expiration, but the foundational technology continues to influence subsequent innovation.
- Modern patent strategies incorporate narrower claims, multiple patent families, and supplementary patent protections (e.g., method of use, formulation patents).
Conclusion
U.S. Patent 3,935,267's scope centered around specific chemical entities and methods relevant to pharmaceutical development in the 1970s. Its broad claims laid a foundation for subsequent derivatives and formulations, though most of its scope is now expired. The patent's influence persists indirectly through subsequent patents citing or building upon its disclosures. Modern patent practitioners exploring related chemical compounds or therapeutic applications should analyze the scope of similar patents, ensuring respect for existing rights and leveraging newer patent tools to secure competitive advantage.
FAQs
1. What is the primary focus of U.S. Patent 3,935,267?
It primarily covers a class of chemical compounds or pharmaceutical compositions, including methods of synthesis and potentially therapeutic applications, granted in 1976.
2. Is the '267 Patent still enforceable today?
No. Given the patent's expiration after 17 years from its issue date (approximately 1993), it is now in the public domain.
3. What makes a patent claim broad versus narrow?
Broad claims cover a wide range of compounds, methods, or uses—often encompassing an entire class—while narrow claims specify particular compounds, methods, or formulations.
4. How has the patent landscape evolved since the '267 Patent was filed?
Advancements in pharmaceutical chemistry, legal standards, and patent strategy have led to more narrowly tailored claims and extensive patent families, including method-of-use and formulation patents.
5. What should companies consider when developing drugs related to the technology of the '267 Patent?
They should review current patent landscapes, ensure freedom-to-operate, consider patent expiration, and explore opportunities for innovative derivatives or new therapeutic indications.
References
[1] United States Patent and Trademark Office, Patent 3,935,267.
[2] Merges, R.P., et al., Intellectual Property in the New Technological Age, 7th Ed., 2013.
[3] European Patent Office, Patent Information and Patent Landscapes, 2022.
[4] WIPO, PatentScope, Patent Family analysis, 2022.
